Multiple Assemblies exist for SMTL entry 4ztm
Irak4-inhibitor co-structure; X-RAY DIFFRACTION 2.66 Å

	SMTL ID 4ztm.1 Ligands 5-(1,3-benzothiazol-2-yl)-2-(cyclopropylamino)-6-{[(1R,2S,3R,4R)-2,3-dihydroxy-4-(hydroxymethyl)cyclopentyl]amino}pyrimidin-4(3H)-one Polypeptides Interleukin-1 receptor-associated kinase 4 Oligo-state monomer
	SMTL ID 4ztm.2 Ligands 5-(1,3-benzothiazol-2-yl)-2-(cyclopropylamino)-6-{[(1R,2S,3R,4R)-2,3-dihydroxy-4-(hydroxymethyl)cyclopentyl]amino}pyrimidin-4(3H)-one Polypeptides Interleukin-1 receptor-associated kinase 4 Oligo-state monomer
	SMTL ID 4ztm.3 Ligands 5-(1,3-benzothiazol-2-yl)-2-(cyclopropylamino)-6-{[(1R,2S,3R,4R)-2,3-dihydroxy-4-(hydroxymethyl)cyclopentyl]amino}pyrimidin-4(3H)-one Polypeptides Interleukin-1 receptor-associated kinase 4 Oligo-state monomer
	SMTL ID 4ztm.4 Ligands 5-(1,3-benzothiazol-2-yl)-2-(cyclopropylamino)-6-{[(1R,2S,3R,4R)-2,3-dihydroxy-4-(hydroxymethyl)cyclopentyl]amino}pyrimidin-4(3H)-one Polypeptides Interleukin-1 receptor-associated kinase 4 Oligo-state monomer